Navigation Links
Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Date:11/12/2009

arterial thrombosis applications, initially in Acute Coronary Syndrome patients undergoing Percutaneous Coronary Intervention. REG2, Regado's second product candidate, consists of a subcutaneously administered formulation of RB006 paired with the IV bolus formulation of RB007. REG2 is currently undergoing phase 1 clinical testing and is intended for use in venous thrombosis indications.

ABOUT APTAMERS

RB006 is a member of a class of compounds called aptamers. Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein. A key unique feature of aptamers derives from the fact that they are formed from nucleic acids. As such, their pharmacologic activity can be controlled by a matched, complementary oligonucleotide active control agent (the Watson-Crick base pair complement of a fraction of the agent to be controlled), which can bind to the aptamer, removing it from its target and reversing it biologic effects.

More information can be found at http://www.regadobio.com.

SOURCE Regado Biosciences


'/>"/>
SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
2. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
3. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
4. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
5. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
6. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
7. Regado Biosciences Establishes Medical Advisory Board
8. Regado Biosciences Expands Medical Advisory Board
9. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
10. Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009
11. Regado Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2009 on September 11, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... NEW YORK , March 2, 2015 ... please scroll to bottom.   Moments ago, ... situations including Sunshine Heart (NASDAQ: SSH ... SURG ), Syneron Medical (NASDAQ: ELOS ), Spectranetics ... THOR ). Analysts Review provides a single unified platform for ...
(Date:3/2/2015)... MIAMI (PRWEB) March 02, 2015 ... a newly formed alliance with Shenzhen HANK Bioengineering ... M.D., Ph.D. The alliance will establish a stem ... Guangdong Province, China in September 2015. , Shenzhen ... by Zhang, an award-winning scientist, microbiologist and virologist, ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... , Feb. 27, 2015 Research and Markets ... "Global Market Report of Trypsin" report to their offering. ... 9002-07-7) aims at providing comprehensive data on Trypsin globally and ... , North America , Latin ... close attention to Trypsin This report focuses on ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2
... 3, 2011 Vermillion, Inc. (NASDAQ: ... received a notice of allowance from the United States Patent ... of biomarkers that could be used in the diagnosis of ... of heart attack and stroke. The patent, entitled ...
... HOPKINTON, Mass., Nov. 3, 2011 Caliper Life Sciences, Inc. ... for the third quarter ended September 30, 2011.  Third quarter ... the same period in 2010.  Organic revenue, which excludes the ... over the third quarter of 2010 and 21% on a ...
... University of Technology (QUT) researchers have developed new ... water and aiding clean-up efforts following nuclear disasters. ... of how to clean up millions of tonnes ... safely store the concentrated waste. Professor Huai-Yong ...
Cached Biology Technology:Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 2Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 3Caliper Life Sciences Reports Third Quarter 2011 Results 2Caliper Life Sciences Reports Third Quarter 2011 Results 3Caliper Life Sciences Reports Third Quarter 2011 Results 4Caliper Life Sciences Reports Third Quarter 2011 Results 5Caliper Life Sciences Reports Third Quarter 2011 Results 6Caliper Life Sciences Reports Third Quarter 2011 Results 7Caliper Life Sciences Reports Third Quarter 2011 Results 8Caliper Life Sciences Reports Third Quarter 2011 Results 9Caliper Life Sciences Reports Third Quarter 2011 Results 10Caliper Life Sciences Reports Third Quarter 2011 Results 11Caliper Life Sciences Reports Third Quarter 2011 Results 12Caliper Life Sciences Reports Third Quarter 2011 Results 13Caliper Life Sciences Reports Third Quarter 2011 Results 14Caliper Life Sciences Reports Third Quarter 2011 Results 15Caliper Life Sciences Reports Third Quarter 2011 Results 16Caliper Life Sciences Reports Third Quarter 2011 Results 17Caliper Life Sciences Reports Third Quarter 2011 Results 18Caliper Life Sciences Reports Third Quarter 2011 Results 19Technology makes storing radioactive waste safer 2
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
(Date:2/24/2015)... 24, 2015 This report analyzes the worldwide markets for ... Face Biometrics, and Voice Biometrics. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific ... , and Latin America . Annual estimates ... a seven-year historic analysis is provided for these markets. Market data ...
(Date:2/18/2015)... Feb. 18, 2015  Cepheid (NASDAQ: CPHD ) ... following conferences, and invited investors to participate via webcast. ... MA Tuesday, March 3, 2015 at 11.20 a.m. ... Orlando, FL Wednesday, March 4, 2015 at ... access the live webcasts for these events, please visit Cepheid,s ...
Breaking Biology News(10 mins):Personal Data Protection Company Launches New Product 2World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2
... ocean conditions such as current directions and water temperature ... young migrating salmon as they move from rivers and ... new research. The findings inform restoration policies and practices ... Northwest. The findings, from ecologists at the Department ...
... studied glass knifefish, a species of three-inch long electric fish ... tries to understand how their tiny brains control complex electrical ... the special "ribbon fin" that knifefish use to swim back ... fish to move forward or backward. Biologists have long wondered ...
... Despite a 12-year action plan calling for reducing the hypoxia ... made, and there is no evidence that nutrient loading to ... researchers have identified some of the biophysical and social barriers ... suggesting that a partnership of researchers work closely with farmers ...
Cached Biology News:Tracking young salmon's first moves in the ocean 2Tracking young salmon's first moves in the ocean 3Tracking young salmon's first moves in the ocean 4A fish that pushes in the wrong direction solves a mystery of animal locomotion 2A fish that pushes in the wrong direction solves a mystery of animal locomotion 3Researchers suggest plan to address hypoxia in Gulf of Mexico 2Researchers suggest plan to address hypoxia in Gulf of Mexico 3
Silica bead method is an economic method of DNA extraction from agarose...
DTT, 25g...
... are commonly used in baculovirus ... grade" agaroses either contain contaminants ... cells or lack the physical ... overlays. Novagen's BacPlaque Agarose is ...
Antibody specific for trimethyl-Lys27 of histone H3. Mouse monoclonal. Antigen: Synthetic peptide derived from histone H3, trimethylated at lysine 27...
Biology Products: